Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core

Bioorg Med Chem. 2021 Dec 15:52:116528. doi: 10.1016/j.bmc.2021.116528. Epub 2021 Nov 20.

Abstract

Tau aggregates represent a critical pathology in Alzheimer's disease (AD) and other forms of dementia. The extent of Tau neurofibrillary tangles across defined brain regions corresponds well to the observed level of cognitive decline in AD. Compound 1 (PI-2620) was recently identified as a promising Tau positron emission tomography tracer for AD and non-AD tauopathies. To evaluate the impact of the N-atom position with respect to Tau- and off-target binding, tricyclic core analogs of PI-2620 with nitrogen atoms at different positions were prepared. Affinity to aggregated Tau was evaluated using human AD brain homogenates, and their off-target binding was evaluated in a monoamine oxidase A (MAO-A) competition assay. The novel tricyclic core derivatives all displayed inferior Tau binding or MAO-A off-target selectivity, indicating PI-2620 to be the optimal design for high affinity binding to Tau and high MAO-A selectivity.

Keywords: Alzheimer’s disease; In silico; Pyridine derivatives; SAR; Tau-binding.

MeSH terms

  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / drug therapy*
  • Brain / metabolism
  • Dose-Response Relationship, Drug
  • Humans
  • Molecular Structure
  • Monoamine Oxidase / metabolism
  • Nitrogen / chemistry
  • Nitrogen / pharmacology*
  • Positron-Emission Tomography
  • Pyridines* / administration & dosage
  • Pyridines* / chemistry
  • Pyridines* / pharmacology
  • Radiopharmaceuticals / chemistry
  • Radiopharmaceuticals / pharmacology*
  • Structure-Activity Relationship
  • tau Proteins / analysis
  • tau Proteins / antagonists & inhibitors*
  • tau Proteins / metabolism

Substances

  • PI-2620
  • Pyridines
  • Radiopharmaceuticals
  • tau Proteins
  • Monoamine Oxidase
  • Nitrogen